Agendia last week made three appointments to its executive team. David Macdonald has been named chief operating officer, Mark Willig has been tapped to be executive vice president of North American sales, and Doug Bradley has been appointed vice president of global marketing.
Macdonald has been involved in commercializing clinical diagnostics and lab services tools at Nanogen, AltheaDx, Behring Diagnostics, and the Nichols Institute. Willig was general manager and chief commercial officer at Exiqon, vice president of global sales for Thermo Fisher's pathology business, and worked at Myriad Genetics and Abbott Diagnostics. Bradley has worked at Coherent Medical, Allergan, SenoRx, and at Vertos Medical.